E (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
>Information in Another Section


EBOLA
ECZEMA +
EDEMA*+
>EHLERS-DANLOS SYNDROME + (See News Articles 2010-2018)
ELECTROCONVULSIVE THERAPY
EMBRYOS/FETAL DEVELOPMENT/PLACENTAL DEVELOPMENT +
ENCEPHALITIS +
ENCEPHALOMYELITIS/EAE*+
ENDOMETRIOSIS +
ENTOURAGE EFFECT (See PHYTOCANNABINOIDS and ENDOCANNABINOIDS)
EPILEPSY/SEIZURES* (See Also EPIDIOLEX in PHYTOCANNABINOIDS)
EPSTEIN-BARR
ESSENTIAL TREMOR (See Also News Articles 2010-2018)
EXERCISE and the ENDOCANNABINOID SYSTEM*+


EBOLA
CBD Protective Against Ebola Virus (article–2014) http://cannabisdigest.ca/cbd-protective-ebola-virus/
Cannabidiol: a potential treatment for post Ebola syndrome? (link to PDF–2016) http://www.ijidonline.com/article/S1201-9712(16)31177-8/abstract


ECZEMA +
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23869687
Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016) http://archderm.jamanetwork.com/article.aspx?articleid=2547236
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721
Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and  alleviate clinical symptoms of atopic eczema (abst–2017)  http://www.jdsjournal.com/article/S0923-1811(16)31025-8/fulltext


EDEMA*+
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis (abst–2010)  https://www.ncbi.nlm.nih.gov/pubmed/20659297
Endocannabinoids and traumatic brain injury (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950
Palmitoylethanolamide restores myelinated-fibre function in patients with hemotherapy induced painful neuropathy (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22229320
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice (full–2012)  http://eurheartj.oxfordjournals.org/content/33/24/3124.full
The cannabinoid receptor-2 is involved in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22525379
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812001062
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxicischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23414569
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707295
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral  leukocyte infiltration following subarachnoid hemorrhage in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067767/
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25058046
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194247/
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain full–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23461/full
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25625355
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25833102
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
top

A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26376816
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017)  http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28707493
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role  of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (abst–2017) https://link.springer.com/article/10.1007%2Fs12035-017-0792-z
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29079445
Bilateral multiple exudative retinal detachments and macular edema in a patient  diagnosed with synthetic cannabinoid (Bonzai) intoxication (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29275529


ELECTROCONVULSIVE THERAPY*+
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of  patients with major depression: a preliminary prospective study (abst–2017)  https://link.springer.com/article/10.1007%2Fs00406-017-0789-7


EMBRYOS/FETAL DEVELOPMENT/PLACENTAL DEVELOPMENT +
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
From Fertilisation to Implantation in Mammalian Pregnancy—Modulation of Early  Human Reproduction by the Endocannabinoid System (full–2010)  http://www.mdpi.com/1424-8247/3/9/2910/htm
A prospective study on intrauterine cannabis exposure and fetal blood flow (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20451334
Expression of cannabinoid receptors in human kidney (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20607655
Characteristics of pregnant illicit drug users and associations between cannabis use and  perinatal outcome in a population-based study (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20171023
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/?tool=pubmed
Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development (full–2011) http://www.placentajournal.org/article/S0143-4004%2811%2900110-X/fulltext
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol (full–2011) http://www.nature.com/ncomms/journal/v2/n11/full/ncomms1559.html
The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility (full–2011) http://humupd.oxfordjournals.org/content/17/3/347.long
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity  glycine transporter subtype 1 inhibitor and GPR55 agonist (full–2011)  http://jpet.aspetjournals.org/content/337/1/236.long
Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst in English–2011) http://www.ncbi.nlm.nih.gov/pubmed/22127663 (abst in Spanish) https://www.neurologia.com/articulo/2011157
Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos (full–2012) http://molehr.oxfordjournals.org/content/19/2/93.full 
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical  development (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full–2012)  http://www.karger.com/Article/FullText/339075
Immunity and early pregnancy events: are endocannabinoids the missing link? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23177537 
Embryonic diapause in humans: time to consider? (full–2013) http://www.rbej.com/content/11/1/92
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2013) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp) of obesity (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827983/
top
Implantation failure in mice with a disruption in Phospholipase C beta 1 gene: lack of embryonic attachment, aberrant steroid hormone signalling and defective endocannabinoid metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632219/
Long-term consequences of perinatal fatty acid amino hydrolase inhibition (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/bph.12500/abstract
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity (full–2013) http://www.placentajournal.org/article/S0143-4004%2813%2900692-9/fulltext
The role of endocannabinoids in pregnancy (download–2013) http://www.reproduction-online.org/content/early/2013/06/06/REP-12-0508.long
Behavioral Responses to Acute and Sub-chronic Administration of the Synthetic Cannabinoid JWH-018 in Adult Mice Prenatally Exposed to Corticosterone (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23296549
Fatty Acid Binding Protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for placental triglyceride accumulation and fetal growth (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25096952
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Gene-Specific Disruption of Endocannabinoid Receptor 1 (cnr1a) by Ethanol Probably Leads to the Development of Fetal Alcohol Spectrum Disorder (FASD) Phenotypes in Japanese Rice Fish (Oryzias latipes) Embryogenesis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25251458
Lipid abundance in zebrafish embryos is regulated by complementary actions of the Endocannabinoid System and Retinoic Acid Pathway (full–2015) http://press.endocrine.org/doi/pdf/10.1210/EN.2015-1315
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo (full–2015) http://www.springerplus.com/content/4/1/804
Endocannabinoid signaling in female reproductive events: a potential therapeutic target? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126134
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26229240
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25931248
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26144572
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26347521
Epigenetic Effects of Cannabis Exposure (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26546076
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
Progesterone and anandamide in pregnancy loss (full–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900515-9/fulltext
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and  psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244

Anandamide restricts uterine stromal differentiation and is critical for complete decidualization (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960165
Anandamide and Decidual Remodeling: COX-2 oxidative metabolism as a key regulator (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26335727
The endocannabinoid 2-arachidonoylglycerol dysregulates the synthesis of proteins by the human syncytiotrophoblast (abst–2015) http://www.sciencedirect.com/science/article/pii/S1388198115002309
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708672
top
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26946127
Exocannabinoids effect on in vitro bovine oocyte maturation via activation of AKT and  ERK1/2 (full–2016) http://www.reproduction-online.org/content/152/6/603.long
Dynamic of expression and localization of cannabinoid-degrading enzymes FAAH and MGLL in relation to CB1 during meiotic maturation of human oocytes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26948343
The endocannabinoid system: an emergent player in human placentation (abst–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300260
Endocannabinoids participate in placental apoptosis induced by hypoxia inducible factor-1 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488203
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27470501
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27959272
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal / early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic  cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK
phosphorylation (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816306612
Conceptus development and transcriptome at preimplantation stages in lactating dairy  cows of distinct genetic groups and estrous cyclic statuses (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27016828
Immunohistochemistry Detected and Localized Cannabinoid Receptor Type 2 in Bovine  Fetal Pancreas at Late Gestation (full–2017)  http://www.ejh.it/index.php/ejh/article/view/2761/2667
A Putative ‘Pre-Nervous’ Endocannabinoid System in Early Echinoderm Development (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866581/
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for
Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
What effects—if any—does marijuana use during pregnancy have on the fetus or child?  (full–2017) http://www.mdedge.com/jfponline/article/141775/pediatrics/what-effects-if-any-does-marijuana-use-during-pregnancy-have
Overactive type 2 cannabinoid receptor induces meiosis in fetal gonads and impairs  ovarian reserve (full–2017)  http://www.nature.com/cddis/journal/v8/n10/full/cddis2017496a.html?foxtrotcallback=true
The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for  morphological development, viability or fertility (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28687732
The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650704/
Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction (full–2017) https://www.karger.com/Article/FullText/477603
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
CB1 cannabinoid receptor drives oocyte maturation and embryo development via  PI3K / Akt and MAPK pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28428264
Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular levels in uterine explants from pregnant mice: pathophysiological implications (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28460003
Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28516445
Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via
endocannabinoid receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28554529
The endocannabinoid system expression in the female reproductive tract is modulated by estrogen (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0960076017301887
Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28847562
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29106691
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29138223
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Interpretation of cannabis findings in the hair of very young children: mission impossible (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29189142
The synthetic cannabinoid WIN-55,212-55,212 induced-apoptosis in cytotrophoblasts  cells by a mechanism dependent on CB1 receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28495606
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived  Neurons (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29230395
Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with  higher endocannabinoid levels (abst–2017) https://academic.oup.com/biolreprod/advance-article-abstract/doi/10.1093/biolre/iox164/4693831?redirectedFrom=fulltext
Neuro-glial cannabinoid receptors modulate signaling in the embryonic avian retina (full-2018) http://www.sciencedirect.com/science/article/pii/S0197018617302280?via%3Dihub


ENCEPHALITIS +
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981070/?toolubmed
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?toolmcentrez
Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Prospects for cannabinoid therapies in viral encephalitis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24021420
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent – case report (link to download–2016) http://www.mppt.hu/folyoirat/1/abstract/? vol=18&issue=3&elsooldal=162


ENCEPHALOMYELITIS/EAE*+
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in  health and disease (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN  regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060486/
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011)  http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26 Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic Experimental Autoimmune Encephalomyelitis (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21406188/abstract/Administration_of_2_arachidonoylglycerol_ameliorates_both_acute_and_chronic_Experimental_Autoimmune_Encephalomyelitis_
top
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst–2012) http://www.jimmunol.org/content/188/1_Supplement/116.7.abstract?sid=b1a0d6c8-40b1-4641-82a4- b6b539cebc6e
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via  modulation of MMP-9 (abst–2012)  http://www.jimmunol.org/content/188/1_Supplement/173.23.abstract?sid=919f9469-cb24-4dbd-9884-1985caa8604a
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Multiple sclerosis and the blood-central nervous system barrier (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24342422
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
Control of experimental spasticity by targeting the degradation of endocannabinoids  using selective fatty acid amide hydrolase inhibitors (link to download–2013)  https://www.researchgate.net/publication/236460848_Control_of_experimental_spasticity_by_targeting_the_degradation_of_endocannabinoids_using_selective_fatty_acid_amide_hydrolase_inhibitors
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice (full–2014) http://embomolmed.embopress.org/content/6/11/1398.long
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25417929
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24440366
top
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent energy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full-2015)
http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0306452215000858
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189763
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)-tetrahydrocannabinol acting through CB1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26590655
top
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism (full–2017) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0783-4
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor  Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues
for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral  blood mononuclear cells of progressive multiple sclerosis patients (abst–2017)  http://www.jns-journal.com/article/S0022-510X(17)30392-1/fulltext
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28757328
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858


ENDOMETRIOSIS +
Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993285/
Endocannabinoid involvement in endometriosis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/
Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176435
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01497.x/full
The molecular connections between the cannabinoid system and endometriosis (full–2012) http://molehr.oxfordjournals.org/content/18/12/563.full
Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462249/
β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23353590
Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24051945
The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23415738
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23515857
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414
Anandamide interferes with human endometrial stromal-derived cell differentiation: An effect dependent on inhibition of cyclooxygenase-2 expression and prostaglandin E2 release (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945481
The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27821707
Cannabinoid receptor 1 contributes to sprouted innervation in endometrial ectopic  growth through mitogen-activated protein kinase activation (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28322749
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (abst–2016)  http://journals.sagepub.com/doi/full/10.1177/1933719116630414
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Endocannabinoids modulate apoptosis in endometriosis and adenomyosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28549792


EPILEPSY/SEIZURES*+
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/?tool=pmcentrez
Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871782/?tool=pubmed
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006205/?tool=pubmed
Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2010.02523.x/full
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909018/
top
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Synergistic neuroprotective therapies with hypothermia (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed
CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20621164
Anticonvulsant effects of GWP42006 in vitro and in vivo in rat (abst-2010)  http://www.physoc.org/proceedings/abstract/Proc%20Physiol%20Soc%2019C117
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy (full–2011) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027196
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis (full–2011) http://brain.oxfordjournals.org/content/134/4/1033.long
Acetaminophen inhibits status epilepticus in cultured hippocampal neurons (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052417/
The secret “spice”: an undetectable toxic cause of seizure (full–2011) http://www.ncbi.nlm.nih.gov/pubmed/23983854
Convulsions Associated with the Use of a Synthetic Cannabinoid Product (link to PDF–2011) http://www.springerlink.com/content/9651q2672027n38g/fulltext.html
Severe toxicity following synthetic cannabinoid ingestion (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165603/
Endocannabinoid system protects against cryptogenic seizures (link to download–2011) http://www.if-pan.krakow.pl/pjp/pdf/2011/1_165.pdf
Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of  audiogenic epilepsy (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21733658
Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four  classical antiepileptic drugs against maximal electroshock-induced seizures in mice  (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21238473/abstract/Synthetic_cannabinoid_WIN_55212_2_mesylate_enhances_the_protective_action_of_four_classical_antiepileptic_drugs_against_maximal_electroshock_induced_seizures_in_mice_
Protective effects of CB1 receptor agonist WIN 55.212-2 in seizure activity in the model of temporal lobe epilepsy (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21469332/abstract/%5BProtective_effects_of_CB1_receptor_agonist_WIN_55_212_2_in_seizure_activity_in_the_model_of_temporal_lobe_epilepsy%5D_
L-Type Calcium Channel Mediates Anticonvulsant Effect of Cannabinoids in Acute and  Chronic Murine Models of Seizure (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21928146
Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22079489
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
Cannabidivarin is anticonvulsant in mouse and rat (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02207.x/pdf
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
top
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full–2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures.12.aspx
Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799958/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (full–2012) http://www.seizure-journal.com/article/S1059-1311%2812%2900057-X/fulltext
Epileptiform activity in the CA1 region of the hippocampus becomes refractory to  attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B receptor activity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350599/
Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase-Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480564/
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Targeting the endocannabinoid system with cannabinoid receptor agonists:  pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy: Patent Application 20120004251 (full–2012) http://www.freshpatents.com/-dt20120105ptan20120004251.php
Internet Highs-Seizures After Consumption of Synthetic Cannabinoids Purchased Online (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22824736
Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of  different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model  (abst–2012) http://www.sciencedirect.com/science/article/pii/S0278584612001601
First European case of convulsions related to analytically confirmed use of the synthetic  cannabinoid receptor agonist AM-2201 (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22936123
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23159379
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23206503
Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22019959
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22206897
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder (full–2013) http://www.biomedcentral.com/content/pdf/1746-6148-9-262.pdf
Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332149/
top
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840466/
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1  receptor-mediated signalling (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764637/
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1  receptor-independent mechanism (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792005/
Stirring the Pot With Estrogens (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697880/
Whole Cannabis Extracts of High Concentration Cannabidiol May Calm Seizures in  Highly Refractory Pediatric Epilepsies (full–2013)  http://hope4childrenwithepilepsy.com/wp-content/uploads/2013/11/Dr.-Gedde-Abstract.pdf
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013) http://www.managedcaremag.com/linkout/2013/1/23
Epidiolex – GW Pharmaceuticals (drug development page–2013) http://www.gwpharm.com/Epidiolex.aspx
The Role of CB1-Receptors in the Proconvulsant Effect of Leptin on Penicillin-Induced  Epileptiform Activity in Rats (abst–2013)  https://www.researchgate.net/publication/236073770_The_Role_of_CB1-Receptors_in_the_Proconvulsant_Effect_of_Leptin_on_Penicillin-Induced_Epileptiform_Activity_in_Rats
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Cannabis and other illicit drug use in epilepsy patients (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/ene.12081/full
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23644464
The role of α2-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756131
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23860329
Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24161913
top
The case for medical marijuana in epilepsy (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz  psychomotor seizure model (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065376/
Modulation of pilocarpine-induced seizures by cannabinoid receptor 1 (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0095922
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Physicians, Medical Marijuana, and the Law (full–2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097232/
Presynaptic mechanisms of neuronal plasticity and their role in epilepsy (full–2014) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00164/full
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996125/
Cannabinoids for epilepsy (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009270.pub3/full
The case for assessing cannabidiol in epilepsy (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12635/full
Seizing an opportunity for the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189640/
ABHD6 Blockade Exerts Antiepileptic Activity in PTZ-Induced Seizures and in Spontaneous Seizures in R6/2 Mice (full–2014) http://www.sciencedirect.com/science/article/pii/S0896627314005765
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12232/full
Cannabidiol: Promise and Pitfalls (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189631/
“Cannabis in the Management and Treatment of Seizures and Epilepsy” (download–2014) Cannabis in the Management and Treatment of Seizures and Epilepsy
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis  Extracts to Treat Diseases (link to upload-2014)  http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
A ‘spicy’ encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure (letter–2014) http://ccforum.biomedcentral.com/articles/10.1186/s13054-014-0553-6
Disease-Modifying Effects of RHC80267 and JZL184 in a Pilocarpine Mouse Model of Temporal Lobe Epilepsy (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cns.12302/full
Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues (full–2014) http://journals.sagepub.com/doi/full/10.1177/0960327114550886
top
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014)  https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
‘Crazy Monkey’ Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24905571
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642454
Cannabinoids for epilepsy: is marijuana an effective treatment for epilepsy? (abst–2014) http://iospress.metapress.com/content/p50752072175783q/?p=00368d67a25c414b9e1ecc38b534bdfc&pi=14
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD),  Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in  Vitro: Potential for the Treatment of Neuronal Hyperexcitability (abst–2014)  http://pubs.acs.org/doi/abs/10.1021/cn5000524
Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25572075
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo  seizures and in vitro epileptiform bursting (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25064144
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal  subpopulation-specific effects on epileptogenesis in the kindling paradigm (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25123336
The interaction between ghrelin and cannabinoid systems in penicillin-induced
epileptiform activity in rats (abst–2014)
http://www.neuropeptidesjournal.com/article/S0143-4179(14)00080-8/fulltext
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of  clobazam and lacosamide in the maximal electroshock-induced seizure model and  chimney test in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25458536
Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic  effects in an in vivo model of partial epilepsy (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25458534
top
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286150
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25448777
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447228
Changes and overlapping distribution in the expression of CB1/OX1-GPCRs in rat hippocampus by kainic acid-induced status epilepticus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446454
Medical marijuana and children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25647865
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868186#sthash.4suBa1in.dpuf
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic  cannabinoid: a case report (abst in English–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25179201 (abst in Japanese)  http://medicalfinder.jp/doi/abs/10.11477/mf.1436102331
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon induced seizures (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/prp2.100/full
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
top

Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499434/
Phytocannabinoids and epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety-like behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Cannabinoids: is there a potential treatment role in epilepsy? (full–2015) http://informahealthcare.com/doi/pdf/10.1517/14656566.2015.1074181
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598436/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full-2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Homer Protein-Metabotropic Glutamate Receptor Binding Regulates Endocannabinoid Signaling and Affects Hyperexcitability in a Mouse Model of Fragile X Syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25740522
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/epi.13060/full
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure  (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666428/
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure activity and oxidative stress in mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25417010
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25592741
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25726258
top

Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25769371
Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796567
Withdrawal Seizures Seen In the Setting of Synthetic Cannabinoid Abuse (abst–2015)  http://www.ajemjournal.com/article/S0735-6757%2815%2900169-2/abstract
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845492
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25882081
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25891509
Influence of arachidonyl-2′-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904357
Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933961
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
JWH-018 impairs sensorimotor functions in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25987201
Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26135674
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26168676
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
top
Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26283212
Marijuana Use in Epilepsy: The Myth and the Reality (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299273
Issues and promise in clinical studies of botanicals with anticonvulsant potential (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26341963
Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26360322
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
Cannabis and Endocannabinoid Signaling in Epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408165
Polypharmacology Shakes Hands with Complex Aetiopathology (abst-2015) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(15)00171-6
Cannabidiol as potential treatment in refractory pediatric epilepsy (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26567560
The effects of adolescent cannabinoid exposure on seizure susceptibility and lethality in adult male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711091
Convulsant effects of high efficacy synthetic cannabinoid JWH-018 in mice (abst-2015) http://www.fasebj.org/content/29/1_Supplement/614.7.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole induced seizure severity in Wistar rats (abst–2015) http://www.epires-journal.com/article/S0920-1211(16)30131-0/abstract
An outbreak of acute delirium from exposure to the synthetic cannabinoid ABCHMINACA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26555732
The Pharmacological Basis of Cannabis Therapy for Epilepsy (full–2016) http://jpet.aspetjournals.org/content/early/2016/01/19/jpet.115.230151.long
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling (full–2016) http://www.nature.com/articles/srep21931
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (full–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9-
Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (full–2016)  http://www.jbc.org/content/290/14/8711.full
Investigational new drugs for focal epilepsy (full–2016)  http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144
Synthetic cannabinoids revealing adrenoleukodystrophy (full–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.phpjournal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30852-X
Turning Up the Heat on Endocannabinoid Signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106110/
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043219/
Medical Marijuana for Epilepsy? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911937/
Investigational new drugs for focal epilepsy (full–2016) http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958898/
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26804027
Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures  (full–2016) http://www.epilepsybehavior.com/article/S1525-5050(15)00695-2/fulltext
Cannabis and Cannabinoids (1st page–2016)  http://jamanetwork.com/journals/jama/article-abstract/2592497
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300069
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26892745
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970948
Cannabidiol and epilepsy: rationale and therapeutic potential (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816301797
LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27159480
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
CB1 Receptor Antagonism Prevents Long-Term Hyperexcitability after Head Injury by of Dynorphin-KOR System and mGluR5 in Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262683
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27285147
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27456262
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
From cannabis to cannabidiol to treat epilepsy, where are we? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27587196
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810514
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
Cannabis and epilepsy: An ancient treatment returns to the fore (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989385
Using Medical Marijuana to Stop Childhood Seizures (news & abstract–2016) http://neurosciencenews.com/thc-cbd-childhood-seizures-3618/
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy (full–2017) http://www.mdpi.com/1422-0067/18/5/900
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent  Epilepsy? (full–2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of  antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
Effects of arachidonyl-2′-chloroethylamide (ACEA) on the protective action of various  antiepileptic drugs in the 6-Hz corneal stimulation model in mice (full–2017)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183873
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions  through conditional genetic rescue in forebrain GABAergic neurons (full–2017)  https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate after-discharges and restores seizure-induced impairment of short and long-term synaptic plasticity (full–2017) https://www.nature.com/articles/s41598-017-11606-1
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in
Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603872/
Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165363
A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—A case report and review of the literature (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721953/
The current status of artisanal cannabis for the treatment of epilepsy in the United States (full–2017) https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf 
Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424589/
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to download–2017)   http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls (link to download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29208697
Interaction between urethane and cannabinoid CB1 receptor agonist and antagonist in penicillin-induced epileptiform activity (click “Free Full PDF” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691717
New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic  Cannabinoids (1st page-2017)  http://www.psychosomaticsjournal.com/article/S0033-3182(16)30124-4/fulltext
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30666-7/fulltext
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30622-9/fulltext
Social factors in marijuana use for medical and recreational purposes (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
Pharmacology of cannabinoids in the treatment of epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28087250
Cannabinoids in treatment-resistant epilepsy: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188044
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy,  epileptogenesis, and epilepsy-related neuroprotection (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30531-5/fulltext
Endocannabinoid-dependent protection against kainic acid-induced long-term  alteration of brain oscillations in guinea pigs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28192082
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
The Direct Actions of Cannabidiol and 2-Arachidonoyl Glycerol at GABAA Receptors  (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661816311392
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28276775
Cannabis and epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(17)30041-0/fulltext
Cannabinoids as hippocampal network administrators (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301405?via%3Dihub
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic  Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397128
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with 
acute recreational drug toxicity to an Emergency Department in London, UK in the first 
half of 2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28421836
Neurological aspects of medical use of cannabidiol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28412918
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28454984
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28478594
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced  Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520841
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic  stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in  developing rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691158
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment  (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28538134
Antiepileptic drugs in clinical development: differentiate or die? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799516
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological 
mechanisms, electroencephalographic profile, and brain cytokine levels (abst–2017) 
http://www.epilepsybehavior.com/article/S1525-5050(17)30322-0/abstract
The potential role of cannabinoids in epilepsy treatment (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28845714
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo 
Neurotoxic Effects of Paraoxon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28803438
Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency 
stabilization in Colorado: a P SCAN Cohort (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28862050
Cannabis use in Epilepsy. Current situation in Argentina and abroad (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28898306
Preferences for Medical Marijuana over Prescription Medications Among Persons Living 
with Chronic Conditions: Alternative, Complementary, and Tapering Uses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28945457
Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A 
case series and review of the literature (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29037744
Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid  Receptor Agonists: From Horizon Scanning to Notification (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29038156
Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB1  receptors and glutamatergic transmission (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0041008X17304155
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced 
damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29105060
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29171003
Simple and fast gas-chromatography mass spectrometry assay to assess delta 9-
tetrahydrocannabinol and cannabidiol in dogs treated with medical cannabis for canine
epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29173160
Cannabinoids for epilepsy: What do we know and where do we go? (abst–2017)   https://www.ncbi.nlm.nih.gov/pubmed/29214639
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Cannabis and epilepsy: An ancient treatment returns to the fore (abst–2017) 
http://www.sciencedirect.com/science/article/pii/S1525505016304127
Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) 
increase the threshold for maximal electroshock-induced seizures in mice (full–2018)  https://www.sciencedirect.com/science/article/pii/S1734114017303511?via%3Dihub
An interaction between warfarin and cannabidiol, a case report (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789126/
Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and  Related Comorbidities (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29372545
top


EPSTEIN-BARR
WIN55,212-2 induces cytoplasation in apoptosis-resistant MCL cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634783/


ESSENTIAL TREMOR
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27545646
Effect of marijuana on Essential Tremor: A case report (abst–2016) http://www.mdsabstracts.org/abstract/effect-of-marijuana-on-essential-tremor-a-case-report/


EXERCISE and the ENDOCANNABINOID SYSTEM*+
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor  Sensitivity in the Striatum (full-2010)  http://www.nature.com/npp/journal/v35/n2/full/npp2009141a.html
Endocannabinoids and voluntary activity in mice: runner’s high and long-term 
consequences in emotional behaviors (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20353785
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional 
behaviours and hippocampal neurogenesis (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20138171
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050879/?tool=pmcentrez
Adipose tissue endocannabinoid system gene expression: depot differences and effects of  diet and exercise (full–2011) http://www.lipidworld.com/content/10/1/194
High-performance sport, marijuana, and cannabimimetics (full–2011) http://jat.oxfordjournals.org/content/35/9/624.long
Effects of exercise stress on the endocannabinoid system in humans under field conditions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22101870
Naloxone and rimonabant reduce the reinforcing properties of exercise in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21707193
Intense exercise increases circulating endocannabinoid and BDNF levels in humans-Possible implications for reward and depression (abst–2011) http://www.psyneuen-journal.com/article/PIIS0306453011002873/abstract?rss=yes
Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high’ (full–2012) http://jeb.biologists.org/content/215/8/1331.long
top
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22943701
Exercise-induced endocannabinoid signaling is modulated by intensity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22990628
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23237313
Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred 
for high voluntary wheel-running behavior (abst–2012)
http://www.sciencedirect.com/science/article/pii/S0091305712000597
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/71
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115292
Exercise Addiction- Diagnosis, Bio-Psychological Mechanisms and Treatment Issues (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24001300
Exercise increases plasma THC concentrations in regular cannabis users (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24018317
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the 
trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23707281
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament (full–2014) 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125187/
Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids? (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12235/full
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple  sclerosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/
Acute Resistance Exercise Induces Antinociception by Activation of the Endocannabinoid System in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139418/
Mechanisms of Exercise-Induced Hypoalgesia (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302052/
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex  Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanol-amide and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models (full–2014)  http://www.nature.com/tp/journal/v4/n5/full/tp201431a.html
Physical activity and the endocannabinoid system: an overview (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24526057
Physical activity and cannabis cessation (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24629045
top
Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an  examination of behavioural consequences (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24696079
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised,  controlled trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24890912
The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/23793235
A runner’s high depends on cannabinoid receptors in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015)  http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
Cannabinoid Receptor 1 and Acute Resistance Exercise – In vivo and In vitro Studies in Human Skeletal Muscle (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796352
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738

Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-
Neuromodulation of Aerobic Exercise—A Review (full–2016) http://journal.frontiersin.org/article/10.3389/fpsyg.2015.01890/full
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to 
cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082783/
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26812592
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28017680
top
The role of exercise training and the endocannabinoid system in atherosclerotic plaque  burden and composition in Apo-E-deficient mice (full–2017)  http://www.sciencedirect.com/science/article/pii/S1109966616302949
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Cannabis: Exercise performance and sport. A systematic review (full–2017) 
http://www.jsams.org/article/S1440-2440(17)30342-0/fulltext
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat (full–2017) 
http://www.sciencedirect.com/science/article/pii/S0014299917307239?via%3Dihub
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity 
Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia   (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28387833
Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28392296
Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1109966617301422
AMPK contributes to aerobic exercise-induced antinociception downstream of 
endocannabinoids (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301983?via%3Dihub
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in 
a rat model of activity-based anorexia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28561272
Voluntary exercise improves cognitive deficits in female dominant-negative DISC1 
transgenic mouse model of neuropsychiatric disorders (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15622975.2017.1323118?journalCode=iwbp20
Moderate and vigorous physical activity patterns among marijuana users: Results from 
the 2007-2014 National Health and Nutrition Examination Surveys (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30275-2/fulltext
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28653665
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis Syndrome (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28664257
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/29388710


Advertisements